Answers are grounded in this paper and cite their sources.
This study examines adverse events and durability of response of SER-109, an investigational microbiome therapeutic comprised of purified Firmicutes spores, compared with placebo for Clostridioides difficile infection.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: